论文部分内容阅读
支气管哮喘是临床常见疾病,其中,大部分支气管哮喘患者经解痉、平喘、吸氧及抗炎等常规治疗,病情可得到缓解,但仍有部分患者,特别是中重度支气管哮喘的患者,经上述治疗后,病情却仍继续恶化。近年来,我们采用五联疗法治疗中重度支气管哮喘64例,获得了满意的疗效,现报告如下。临床资料1一般资料:本研究所选治疗对象为64例,均为我院于2009年11月～2010年11月间收治的中重度支气管哮喘患者,按照住院治疗的先后顺序随机分为治疗组43例和对照组各21例。治疗组男22例,女21例;年龄最小18岁,最大76岁,平均52.4±5.7岁;病史最短1年,最长15年,平均9.3年。对照组男11例,女10例;年龄最小14岁,最大72岁,平均50.6±5,3岁;病史最短2年,最长17年,平均11.2年。2组性别、年龄、病史以及病情等方面,经统计学处理,无显著性差异,具有可比性。
Bronchial asthma is a common clinical disease, of which, most patients with bronchial asthma by antispasmodic, antiasthmatic, oxygen and anti-inflammatory and other conventional treatment, the condition can be eased, but there are still some patients, especially in patients with moderate to severe bronchial asthma, After the above treatment, the condition still continues to deteriorate. In recent years, we use five-therapy in the treatment of 64 cases of moderate and severe bronchial asthma, obtained satisfactory results, are as follows. Clinical data 1 General Information: The study selected the treatment of 64 patients were in our hospital in November 2009 ~ November 2010 admitted to moderate and severe bronchial asthma patients, according to the order of hospitalization were randomly divided into treatment group 43 cases and control group of 21 cases. The treatment group, 22 males and 21 females; the youngest 18 years old, the largest 76 years old, with an average of 52.4 ± 5.7 years; the shortest history of 1 year, up to 15 years, an average of 9.3 years. The control group, 11 males and 10 females; the youngest 14 years old, maximum 72 years old, an average of 50.6 ± 5,3 years old; the shortest history of 2 years, a maximum of 17 years, an average of 11.2 years. 2 groups of gender, age, medical history and illness, etc., by statistical analysis, no significant difference, comparable.